Trial record 1 of 1 for:    s1304
Previous Study | Return to List | Next Study

S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Southwest Oncology Group
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT01903811
First received: July 16, 2013
Last updated: April 12, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)